Media Contact:
Kristy Marks
Kristy.marks@bausch.com
(908) 927-0683
Teresa Panas
teresa@tgpcomm.com
(973) 809-8590
BAUSCH + LOMB INTRODUCES 23-GAUGE BI-BLADE® DUAL PORT VITRECTOMY CUTTER FOR THE STELLARIS ELITE™ VISION ENHANCEMENT SYSTEM
New Cutter Joins 25- and 27-Gauge Bi-Blade Probes, Offers Enhanced Efficiency
BRIDGEWATER, N.J., July 22, 2019 – Bausch + Lomb, a leading global eye health company, today announced the introduction of the 23-gauge Bi-Blade® dual port vitrectomy cutter for the Stellaris Elite™ vision enhancement system. The new probe joins the available 25- and 27-gauge Bi-Blade® cutters as the most efficient option in the Bi-Blade portfolio. All Bi-Blade cutters double effective cut rates to increase flow and efficiency compared to single-port probes.
“Retina surgeons really appreciate the significant advantages that the Bi-Blade cutters offer,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “Now surgeons who prefer the benefits of a 23-gauge probe can enjoy enhanced efficiency and stability that the recently introduced 25-gauge and 27-gauge Bi-Blade cutters offer to address a wide range of procedural needs.”
While single-port cutters cut only in the forward direction, Bi-Blade cutters’ dual-edge blade cuts in both the forward and backward directions, enabling two cuts per cycle. This innovative design used with the Stellaris Elite offers an effective 15,000 cuts per minute (cpm) rate, resulting in increased flow efficiency and control compared to prior generation guillotine cutters.
“The 25- and 27-gauge Bi-Blade dual port cutters continue to be critical tools in my surgical armamentarium – delivering significant advantages over single-port cutters,” said Sunir Garg, M.D., professor of ophthalmology, Wills Eye Hospital, Philadelphia, PA. “I look forward to the efficiency benefits of the new 23-gauge design, which is also expected to allow for reduced traction and increased control.”
To learn more and experience the Bi-Blade probes first hand, visit the Bausch + Lomb booth (#606) at the American Society of Retina Specialists meeting, July 26-30, 2019 in Chicago.
About Stellaris Elite™ Vision Enhancement System
The Stellaris Elite™ vision enhancement system is Bausch + Lomb’s phacoemulsification surgical platform, which offers both cataract and retina capabilities. Its key features include:
- the Adaptive Fluidics™ chamber stabilization system, which combines precise aspiration control with predictive infusion management to create a highly responsive and controlled surgical environment;
- the Attune® energy management system, which utilizes highly efficient emulsification to complement Adaptive Fluidics and deliver efficient, low energy, controlled lens removal;
- a variety of vitrectomy cutters operating up to an effective 15,000 cpm, and
- a comprehensive portfolio of high-performance laser probes.
Surgeons also have the ability to seamlessly integrate other technologies on Stellaris Elite, such as the Vitesse™ hypersonic vitrectomy system, which is available exclusively on that platform.
Please see www.bauschretina.com for Important Safety Information on the Stellaris Elite™ vision enhancement system.
About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.
###
Stellaris Elite, Adaptive Fluidics, Attune and Vitesse are trademarks of Bausch & Lomb Incorporated or its affiliates
Bi-Blade is a trademark of Medical Instrument Development Laboratories, Inc. used by agreement.
Any other product/brand names are trademarks of the respective owners.
© 2019 Bausch & Lomb Incorporated or its affiliates.
SEP.0016.USA.19
United States
